Studying a new insulin sensitizer for type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had type 1 diabetes for at least one year.
- You are between 18 and 45 years old.
- Your latest A1c is below 10%.
- You have a BMI between 18 and 35, and either a BMI of 25 or higher or use at least 0.5 units of insulin per kilogram of body weight each day.
- You currently use a closed-loop automated insulin delivery system that works with a Dexcom G7 continuous glucose monitor.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a smart insulin pump and continuous glucose monitor system that adjusts insulin automatically and uses behavior support to improve blood sugar control. It's for people with type 1 diabetes who have used an approved automated insulin delivery system recently and are willing to use study devices.
This study tests a new medication to see if it can improve how your body responds to insulin and boost your cells' energy (mitochondrial function). It is for adults with type 1 diabetes who are already on insulin and have good overall health.
This study tests a device that measures both glucose and ketone levels continuously. It may help people with type 1 diabetes better manage their condition by providing real-time data.
This study tests a new medication called cadisegliatin added to insulin therapy in people with type 1 diabetes who use an insulin pump with automated features. The goal is to see if this combination helps keep blood sugar in a healthier range more of the time.
This study tests an upgraded automated insulin pump system that uses artificial intelligence to better predict and prevent blood sugar swings. If you have Type 1 Diabetes and already use an automated insulin pump, this trial may help you achieve better blood sugar control.
This study compares a new automated insulin delivery algorithm (AIDANET) in two modes: fully closed-loop (no user input needed) versus hybrid closed-loop (user still gives some insulin for meals). It tests how well the algorithm works in real-life settings for adults with type 1 diabetes.
Hear when a new Glycemic Control for Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.